Tag: property

HANNIBAL, Ohio, June 08, 2026 (GLOBE NEWSWIRE) -- Long Ridge Energy LLC (“LRE”) is announcing its first quarter 2026 investor call for Thursday, June 11, 2026 at 3:00 PM ET. LRE comprises the electric power and natural gas business of Long Ridge Energy & Power LLC (“LREP”). LREP is a wholly owned portfolio company of FTAI Infrastructure, Inc. (Nasdaq: FIP). The conference call may be accessed by registering via the following link: https://register-conf.media-server.com/register/BI863a2ce8dbbb4ea0916ae4e6f81c8d7b. Once registered, participants will receive a dial-in and unique pin to access the call.

The 268-unit Class A multifamily community in Chesapeake’s Greenbrier submarket is backed by long-term capital from Bonaventure’s high-net-worth investor network with long-term HUD financing for a lasting community investment

Basel, June 8th, 2026 – Novartis will present data from 10 abstracts at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2026, spanning Rhapsido^®  (remibrutinib) clinical trial results and real-world evidence on patient burden and treatment experience. Highlights include two late-breaking oral presentations; the Phase III RemIND trial for Rhapsido in chronic inducible urticaria (CIndU) and extension data from the Phase IIIb REMIXED trial in chronic spontaneous urticaria (CSU).

“The Rhapsido presentations at EAACI 2026 expand our understanding of BTK inhibition across multiple immune-mediated diseases and provide evidence of its potential to make a meaningful impact for patients who continue to face significant burden and limited treatment options,” said Angelika Jahreis, Global Head, Immunology Development, Novartis. “Novartis will present Rhapsido data from a long-term extension trial in chronic spontaneous urticaria, Phase III data in three types of chronic inducible urticaria, and early Phase II dose-response analysis for food allergy – together providing scientific evidence for its impact across numerous diseases.”

Abstracts accepted by EAACI include: